News Focus
News Focus
icon url

hoffmann6383

10/08/22 7:55 AM

#520259 RE: jammy32 #520257

this comparison is laughable. comparing a pre revenue Biotech to some of the biggest companies in the world.

seems like pre revenue biotechnology companies is not where one should invest if one thinks they should be comparable to Apple, Microsoft or Tesla AS A PRE REVENUE BIOTECH.

LOLOLOLOL

have a great one jammy!
icon url

biosectinvestor

10/08/22 8:46 AM

#520268 RE: jammy32 #520257

Clearly not true Re NWBO. And those other companies are different industries.

Even so, Microsoft was not profitable for its first decade, which is hard to do with a software company.

Drug development and new biotech platform and technology development are completely different animals. Decades of development with no marketable product and not income is typical. It doesn’t mean that nothing was done and no shareholder value was created, and the 5 year return here is quite good for a biotech and for any investment generally.